Table 5 Logistic regression showing unadjusted and 5 distinctive adjusting models for AKI, RRT and 28 days mortality risk between MELD eras

AKI risk by performing transplantation in Post MELD era

 Unadjusted

0.68

0.48, 0.97

0.03

 Model 1—Adjusted for age and gender

0.69

0.49, 0.97

0.03

 Model 2—Adjusted for age, gender, diabetes, hypertension, BMI and MELD

0.59

0.41, 0.86

 < 0.01

 Model 3—Adjusted for age, gender, diabetes, hypertension, BMI, MELD and eGFR

0.60

0.41, 0.87

 < 0.01

 Model 4—Adjusted for age, gender, diabetes, hypertension, BMI, MELD, eGFR, Vasopressor (During and after transplant), Transfusion, First week Tacrolimus peak level and Nephrotoxic drug exposure

0.46

0.24, 0.85

0.01

 Model 5—Adjusted for age, gender, diabetes, hypertension, BMI, MELD, eGFR, Vasopressor (During and after transplant), Transfusion, First week Tacrolimus peak level, Nephrotoxic drug exposure, Acute liver rejection, Sepsis and SAPS 3

0.49

0.26, 0.92

0.02

RRT risk by performing transplantation in Post MELD era

 Unadjusted

1.95

1.40, 2.71

 < 0.01

 Model 1—Adjusted for age and gender

1.99

1.43, 2.78

 < 0.01

 Model 2—Adjusted for age, gender, diabetes, hypertension, BMI and MELD

1.61

1.12, 2.32

 < 0.01

 Model 3—Adjusted for age, gender, diabetes, hypertension, BMI, MELD and eGFR

1.73

1.20, 2.50

 < 0.01

 Model 4—Adjusted for age, gender, diabetes, hypertension, BMI, MELD, eGFR, Vasopressor (During and after transplant), Transfusion, First week Tacrolimus peak level and Nephrotoxic drug exposure

1.89

0.94, 3.80

0.07

 Model 5—Adjusted for age, gender, diabetes, hypertension, BMI, MELD, eGFR, Vasopressor (During and after transplant), Transfusion, First week Tacrolimus peak level, Nephrotoxic drug exposure, Acute liver rejection, Sepsis and SAPS 3

2.11

1.01, 4.43

0.04

30 days mortality risk by performing transplantation in Post MELD era

 Unadjusted

1.32

0.78, 2.23

0.29

 Model 1—Adjusted for age and gender

1.35

0.79, 2.29

0.26

 Model 2—Adjusted for age, gender, diabetes, hypertension, BMI and MELD

1.37

0.78, 2.40

0.26

 Model 3—Adjusted for age, gender, diabetes, hypertension, BMI, MELD and eGFR

1.31

0.79, 2.44

0.25

 Model 4—Adjusted for age, gender, diabetes, hypertension, BMI, MELD, eGFR, Vasopressor (During and after transplant), Transfusion, First week Tacrolimus peak level and Nephrotoxic drug exposure

0.11

0.02, 0.52

 < 0.01

 Model 5—Adjusted for age, gender, diabetes, hypertension, BMI, MELD, eGFR, Vasopressor (During and after transplant), Transfusion, First week Tacrolimus peak level, Nephrotoxic drug exposure, Acute liver rejection, Sepsis and SAPS 3

0.13

0.02, 0.60

 < 0.01